Skip to content
Buy This GLP
← Research
Evidence

Semaglutide vs Sleeve Gastrectomy and Bypass: Three-Year Out-of-Pocket Costs

Among 6,748 insured patients with type 2 diabetes and a BMI of 35 or more, three-year out-of-pocket cost was $7,752 on semaglutide against $5,980 for sleeve gastrectomy. The analysis found no statistically significant difference in total spending.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team7 min read
Three-year out-of-pocket cost, insuredsemaglutide$7,752gastric bypass$6,591sleeve gastrectomy$5,980Total spending across all three: not significantly different.

The analysis of when medication can cost more than bariatric surgery uses published prices to estimate a break-even point. This study used claims for 6,748 patients with a BMI of at least 35 and type 2 diabetes to compare costs from insurance records [1].

Over three years, semaglutide carried the highest out-of-pocket cost at $7,752, against $5,980 for sleeve gastrectomy and $6,591 for gastric bypass. The analysis found no statistically significant difference in total spending, which included payments by the insurer.

On outcomes the surgical arms did better in places. Compared with semaglutide, sleeve gastrectomy was associated with fewer long-term admissions (HR 0.79, 95% CI 0.72–0.86) and fewer major adverse cardiovascular events (HR 0.79, 95% CI 0.66–0.93). Gastric bypass also showed fewer such events (HR 0.71, 95% CI 0.59–0.88) while showing more emergency visits (HR 1.36) and more inpatient admissions (HR 1.25).

Read those outcome numbers with the population in mind. The surgical patients started with higher BMI and more comorbidities. The authors adjust with inverse probability weighting, generalized linear models and instrumental variables, which narrows the problem without removing it, and none of it makes this a randomized comparison.

The review of GLP-1 cost-effectiveness explains how economic models compare spending and health outcomes over time. If surgery is under consideration, the guide to GLP-1 use around bariatric surgery summarizes studies on treatment timing. A separate review of treatment after weight regain covers people who already had surgery. Ask the care team which evidence applies to your situation.

Frequently asked

Is semaglutide more expensive than bariatric surgery?
For the insured patients studied, it cost more out of pocket over three years — $7,752 against $5,980 for sleeve gastrectomy — while total spending including the insurer's share was not significantly different.
Do these numbers apply if I am paying cash?
The study used insurance claims. For a cash comparison, ask for written quotes that include medication or surgery and any separate care charges.
Did surgery produce better outcomes?
Both surgical groups had fewer major cardiovascular events. Sleeve gastrectomy was associated with fewer long-term admissions, while the bypass group had more inpatient admissions. These were adjusted associations in insurance claims.

Sources

  1. [1] Chhabra KR, Gencerliler N, Orandi BJ, Wang VH, et al. (2026). Semaglutide vs. Bariatric Surgery: Comparing Costs and Clinical Outcomes in Patients With Diabetes and Obesity Obesity (Silver Spring, Md.). PMID 42089543

Where to get it

The cheapest GLP-1

Every seller that publishes a price, ordered lowest first on the standing month-to-month rate, plus the question to ask before you pay any of them.

See the board →

More in Evidence